Similar articles for PMID: 17346123

Year	Number of Results
1906	1
1998	1
1999	2
2000	1
2001	1
2002	2
2003	3
2004	3
2005	6
2006	6
2007	6
2008	4
2009	10
2010	7
2011	4
2012	5
2013	9
2014	9
2015	6
2016	6
2017	2
2018	2
2019	1
2020	3
2021	2
2022	4
2024	0

1

Statins in the prevention of cardiovascular events in patients with renal failure.

Buemi M, Floccari F, Nostro L, Campo S, Caccamo C, Sturiale A, Aloisi C, Giacobbe MS, Frisina N. Buemi M, et al. Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. doi: 10.2174/187152907780059119. Cardiovasc Hematol Disord Drug Targets. 2007. PMID: 17346123 Review.

2

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2013 Sep 11;2013(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Cochrane Database Syst Rev. 2013. PMID: 24022428 Free PMC article. Review.

3

[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].

Karie S, Launay-Vacher V, Deray G, Isnard-Bagnis C. Karie S, et al. Presse Med. 2006 Feb;35(2 Pt 1):219-29. doi: 10.1016/s0755-4982(06)74557-2. Presse Med. 2006. PMID: 16493350 Review. French.

4

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Cochrane Database Syst Rev. 2014. PMID: 24880031 Updated. Review.

5

HMG-CoA reductase inhibitors and the kidney.

Campese VM, Hadaya B, Chiu J. Campese VM, et al. Curr Hypertens Rep. 2005 Oct;7(5):337-42. doi: 10.1007/s11906-005-0066-4. Curr Hypertens Rep. 2005. PMID: 16157074 Review.

6

Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

Connor A, Tomson C. Connor A, et al. BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949. BMJ. 2009. PMID: 19696089 No abstract available.

7

[Statins and kidney disease].

Bigazzi R, Grimaldi D, Bianchi S. Bigazzi R, et al. G Ital Nefrol. 2012 Mar-Apr;29(2):160-73. G Ital Nefrol. 2012. PMID: 22538946 Review. Italian.

8

Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.

Manca-di-Villahermosa S, Taccone-Gallucci M, Maccarrone M. Manca-di-Villahermosa S, et al. Kidney Int. 2009 Jun;75(12):1354-1355. doi: 10.1038/ki.2009.107. Kidney Int. 2009. PMID: 19483750 Free article. No abstract available.

9

Cardiovascular disease in patients with renal disease: the role of statins.

Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F; AURORA Study Group. Fellström B, et al. Curr Med Res Opin. 2009 Jan;25(1):271-85. doi: 10.1185/03007990802622064. Curr Med Res Opin. 2009. PMID: 19210158 Review.

10

[Statins in chronic renal disease].

Ferreira SR, Rocha AM, Saraiva JF. Ferreira SR, et al. Arq Bras Cardiol. 2005 Oct;85 Suppl 5:45-9. Epub 2006 Jan 2. Arq Bras Cardiol. 2005. PMID: 16400399 Free article. Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year